Chemplast Sanmar Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 13 Jun 2026 | Chemicals & Petrochemicals | Market Cap: ₹2.9K Cr
PVC market demand in CY '26 expected to be stable or marginally up after a ~1% drop in CY '25 (4.3 million tons). Chemplast Sanmar anticipates long-term stable growth in the Paste PVC segment, driven by sustained demand from sectors like automobiles and footwear, alongside irrigation needs in agriculture (Page 19).
From Chemplast Sanmar Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹177
Market Cap
₹2.9K Cr
How does Chemplast Sanmar Ltd rank in Chemicals & Petrochemicals?
Compare Chemplast Sanmar Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Chemplast Sanmar Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹-45 Cr.
Full financials →📊 Revenue & Sales Performance
- →PVC market demand in CY '26 expected to be stable or marginally up after a ~1% drop in CY '25 (4.3 million tons).
- →Paste PVC market shows sustained growth potential, driven by robust demand in automobiles, footwear, and irrigation sectors.
- →Irrigation-related demand is expected to grow due to increasing use of drip/sprinkler systems and government subsidy schemes (NABARD).
- →Specialty Chemicals segment sees positive trajectory despite near-term agrochemical sector slowdown; INR1,000 crore revenue target expected next financial year from custom manufacturing.
- →R32 refrigerant capacity to expand to 14,000 metric tons by end of CY '26, targeting domestic and export markets.
- →Overall capital allocation prioritizes Specialty and higher-value businesses for long-term growth.
- →Suspended PVC sales volume demand expected to remain muted in short term, with possible recovery after geopolitical stabilization.
📈 Profitability & Margins
- →Chemplast Sanmar anticipates long-term stable growth in the Paste PVC segment, driven by sustained demand from sectors like automobiles and footwear, alongside irrigation needs in agriculture (Page 19).
- →Specialty Chemicals and Custom Manufacturing divisions show positive medium to long-term outlook, with expected revenue reaching around INR1,000 crores possibly by next financial year despite near-term slowdowns (Pages 8-13).
- →Operational focus remains on cost optimization, capacity utilization, and expanding specialty portfolio to drive more stable, value-accretive growth (Page 6).
- →Q4 FY26 showed EBITDA growth to INR194 crores; however, net loss of INR45 crores due to exceptional items and market volatility impact (Page 6).
- →Impairment provisions in Suspension PVC signal cautious near-term outlook due to pricing pressures and volatility, although government duties (7.5% import duty) may improve spreads post-June (Pages 9-11).
- →Overall, growth expected to be moderate with cyclicality and external market factors influencing profitability in the near term.
🏗️ Capital Expenditure Plans
- →Chemplast Sanmar's capital allocation priority is focused on Specialty businesses, including the expansion of Paste PVC capacity and investments in custom manufacturing and ref gases (Specialty portfolio).
- →The company is investing in ref gases linked to Specialty businesses.
- →A committee of independent directors has been formed to evaluate the overall business portfolio, potential reorganization, and M&A opportunities to enhance long-term stakeholder value.
- →Future capex decisions will be influenced by the committee's findings, focusing on capital employment and mitigating cyclical commodity risks.
- →No specific timelines or amounts for future capex were disclosed, but the intent to move away from cyclical commodity dependence towards Specialty areas is clear.
- →For R32 capacity, short-term raw material sourcing is tied up, and long-term logistics and supply agreements are in progress.
- →The committee is also tasked with reviewing whether capital deployment strategies and business restructuring are needed for sustainable growth.
💰 Fundraising & Capital Structure
- →There is no specific mention of any current or planned new fundraising through debt or equity in the transcript.
- →The management's focus is on capital allocation prioritizing Specialty businesses, such as Paste PVC capacity expansion, custom manufacturing, and ref gases.
- →A committee has been formed to holistically review the business portfolio and explore potential reorganizations or M&A opportunities to unlock value.
- →Capital allocation and future capex decisions are being evaluated with an aim to avoid commodity cycle risks and create long-term value.
- →The discussion suggests a cautious approach towards future investments without explicit fundraising announcements at this stage.
📋 Order Book & Pipeline
- →The company currently has Letters of Intent (LOIs) for 6 out of 17 commercial molecules in its Custom Manufacturing (CDMO) business.
- →The pipeline includes 45 molecules overall, with 17 commercial and the rest at various development stages.
- →Revenue targets for the CDMO business aim to reach around INR 1,000 crores next financial year, albeit with a delay of about 12 months due to agrochemical sector slowdown.
- →The future orderbook is positive, with good engagement from innovator customers seeking to diversify supplier bases in India.
- →Momentum continues in new product development, with a growing basket of molecules quarter-on-quarter.
- →The CDMO business anticipates steady ramp-up of orders, supported by new resources in Europe and Japan to expand market reach.
Key Metrics
Continue your research
What Chemplast Sanmar's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- NOCIL (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
- Indo Borax & Chemicals Ltd (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
- Rossari Biotech (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
- Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…
Frequently Asked Questions
What were Chemplast Sanmar Ltd Q4 FY26 results?
PVC market demand in CY '26 expected to be stable or marginally up after a ~1% drop in CY '25 (4.3 million tons). Chemplast Sanmar anticipates long-term stable growth in the Paste PVC segment, driven by sustained demand from sectors like automobiles and footwear, alongside irrigation needs in agriculture (Page 19).
What is Chemplast Sanmar Ltd share price analysis?
Chemplast Sanmar Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹2,911 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemplast Sanmar Ltd planning capital expenditure?
Chemplast Sanmar's capital allocation priority is focused on Specialty businesses, including the expansion of Paste PVC capacity and investments in custom manufacturing and ref gases (Specialty portfolio).
Keep Chemplast Sanmar Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.